Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Pharma Insight ApS
APS
Active
CVR 40637117
Mathildevej 10, 1. th
All other professional, scientific and technical activities n.e.c. · NACE 7499
Est. 2019
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 138K
-909% vs 2023
EBITDA margin
100.0%
+909% vs 2023
Equity ratio
70.5%
Financial strength
Net profit 2024
DKK 118K
+724% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK 138K
-909%
EBITDA
DKK 138K
+909%
Net profit
DKK 118K
+724%
Total assets
DKK 206K
+335%
Equity
DKK 145K
+431%
Employees
1
—
Company information
Legal name
Pharma Insight ApS
CVR number
40637117
Legal form
Anpartsselskab
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
1. juli 2019
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive konsulentvirksomhed indenfor medicinalbranchen samt enhver i forbindelse hermed stående virksomhed.
Contact
Address
Mathildevej 10, 1. th
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in All other professional, scientific and technical activities n.e.c.
Companies in Frederiksberg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
1.059
725
-27
-17
138
Staff expenses
-848
-662
-1
-0
-0
EBITDA
245
64
-28
-17
138
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
245
64
-28
-17
138
Net financials
-2
-1
2
-2
-1
Profit before tax
242
63
-27
-19
138
Tax
58
15
-0
-0
20
Net profit
185
48
-27
-19
118
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
499
409
156
47
206
Equity
225
273
146
27
145
Long-term debt
0
0
0
0
0
Short-term debt
274
136
10
20
61
Total debt
274
136
10
20
61
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2020
2024
Equity ratio
70.5%
This company
38.2%
Market median
+85% vs market
2020
2024
Return on equity
81.2%
This company
18.4%
Market median
+341% vs market
2020
2024
Net profit margin
85.0%
This company
8.1%
Market median
+949% vs market
2020
2024
Asset turnover
0.67×
This company
1.12×
Market median
-40% vs market
2020
2024
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2019-07-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
MK
Marianne Kock
Management
Management
2019
—
—
PK
Peter Kock
Management
Management
2019
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Peter Kock Holding ApS
Company
100.0%
100.0%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Peter Kock Holding ApS
Pharma Insight ApS
(this company)
Board network connections
Board members of Pharma Insight ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Marianne Kock
Management
0 companies
Peter Kock
Management
0 companies